DAVID
BERNARDO ORDIZ
PROFESORA SUSTITUTA/PROFESOR SUSTITUTO
![Foto de DAVID](/img/nophoto.png)
![Foto de Hospital Universitario de la Princesa](/img/noimage_org.png)
Hospital Universitario de la Princesa
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (32)
2024
-
Circulating immunome fingerprint in eosinophilic esophagitis is associated with clinical response to proton pump inhibitor treatment
Frontiers in Immunology, Vol. 15
-
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients
Inflammatory Bowel Diseases, Vol. 30, Núm. 2, pp. 167-182
2023
-
Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress
Frontiers in immunology, Vol. 14, pp. 1185517
2022
-
Metabolomics study of COVID-19 patients in four different clinical stages
Scientific reports, Vol. 12, Núm. 1, pp. 1650
2021
-
Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies
Scientific Reports, Vol. 11, Núm. 1
-
Lunasin Peptide is a Modulator of the Immune Response in the Human Gastrointestinal Tract
Molecular Nutrition and Food Research, Vol. 65, Núm. 12
2020
-
A quick flow cytometry protocol to assess Helicobacter pylori viability
Journal of Microbiological Methods, Vol. 177
-
Serum adipokines as non-invasive biomarkers in Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease
European Journal of Gastroenterology and Hepatology, Vol. 32, Núm. 5, pp. 588-596
2019
-
Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
Therapeutic Advances in Gastroenterology, Vol. 12
-
Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients
Digestive Diseases and Sciences, Vol. 64, Núm. 3, pp. 846-854
-
Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU
Alimentary Pharmacology and Therapeutics, Vol. 49, Núm. 4, pp. 419-428
-
Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease
Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386
-
Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
Therapeutic Advances in Gastroenterology, Vol. 12
-
Immunomodulatory effect of gut microbiota-derived bioactive peptides on human immune system from healthy controls and patients with inflammatory bowel disease
Nutrients, Vol. 11, Núm. 11
-
Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity
Immunity, Vol. 50, Núm. 2, pp. 446-461.e9
-
Peptides encrypted in the human intestinal microbial-exoproteome as novel biomarkers and immunomodulatory compounds in the gastrointestinal tract
Journal of Functional Foods, Vol. 52, pp. 459-468
-
Role of food proteins and bioactive peptides in inflammatory bowel disease
Trends in Food Science and Technology, Vol. 88, pp. 194-206
2018
-
CD16+ macrophages mediate fibrosis in inflammatory bowel disease
Journal of Crohn's and Colitis, Vol. 12, Núm. 5, pp. 589-599
-
Human Intestinal Dendritic Cells in Inflammatory Bowel Diseases
Molecular Nutrition and Food Research, Vol. 62, Núm. 7